IMVT
Immunovant Inc
30.30$
-5.6%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -3,979.9% | – | – | – | -69,148.1% | – | – | – | – | -1,753.4% | -5,839.4% | |
| – | – | 4.3% | – | – | – | 68.1% | – | – | – | – | 1.3% | 5.6% | |
| – | – | 645.3% | – | – | – | 7,304.4% | – | – | – | – | 194.1% | 718.6% | |
| – | – | 375.0% | – | – | – | -10,003.8% | – | – | – | – | 210.4% | 1,020.8% | |
| – | – | 10.0% | – | – | – | 125.6% | – | – | – | – | 0.0% | 0.1% | |
| – | – | -10.0% | – | – | – | -125.6% | – | – | – | – | – | – | |
| – | – | 103.0% | – | – | – | 281,632.5% | – | – | – | – | 283.3% | 8,639.0% | |
| – | – | -3,704.8% | – | – | – | 212,053.8% | – | – | – | – | -1,470.2% | 2,803.2% | |
| – | – | -3,989.9% | – | – | – | -69,273.8% | – | – | – | – | -1,753.4% | -5,839.5% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.